| 000 | 03014nam a2200421 i 4500 | ||
|---|---|---|---|
| 999 |
_c112738 _d112738 |
||
| 001 | 112738 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230223130207.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 190424s2019 gw a o |||| 0|eng d | ||
| 020 | _a9783030113926 | ||
| 024 | 7 |
_a10.1007/978-3-030-11392-6 _2doi |
|
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC643 _b2019 EB |
|
| 245 | 0 | 0 |
_aChronic Lymphocytic Leukemia _cedited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky |
| 264 | 1 |
_aCham _bSpringer International Publishing _c2019 |
|
| 300 |
_a1 recurso en línea (VI, 179 páginas) _b23 ilustraciones, 19 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 |
_aHematologic Malignancies _x2197-9766 |
|
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _aPathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities. | |
| 520 | 3 | _aThis book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed. . | |
| 988 | _aSpringer_Medicine_2019 | ||
| 650 | 7 |
_aLeucemia linfática crónica _2embne _9667051 |
|
| 700 | 1 |
_aHallek, Michael. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aEichhorst, Barbara. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aCatovsky, Daniel. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 |
_aSpringerLink (Online service) _9106996 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030113919 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030113933 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-11392-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_dz _b02/2023 _eb _zSI |
||